Please select the option that best describes you:
How do you approach frontline treatment for an elderly patient with adult T-cell leukemia-lymphoma (ATL)?
What factors do you consider in choosing between BV-CHP/BV-CHEP vs DA-EPOCH/CHOEP with or without mogamulizumab?